Cargando…

Multivariate gene expression‐based survival predictor model in esophageal adenocarcinoma

BACKGROUND: Despite the recent development of molecular‐targeted treatment and immunotherapy, survival of patients with esophageal adenocarcinoma (EAC) with poor prognosis is still poor due to lack of an effective biomarker. In this study, we aimed to explore the ceRNA and construct a multivariate g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Maoyuan, Wang, Jingsong, Yuan, Meng, Ma, Zeliang, Bao, Yongxin, Hui, Zhouguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529573/ https://www.ncbi.nlm.nih.gov/pubmed/32869505 http://dx.doi.org/10.1111/1759-7714.13626

Ejemplares similares

Survival of Neoadjuvant and Adjuvant Therapy Compared With Surgery Alone for Resectable Esophageal Squamous Cell Carcinoma: A Systemic Review and Network Meta-Analysis
por: Ma, Zeliang, et al.
Publicado: (2021)

Additional Radiotherapy With or Without Chemotherapy Following Endoscopic Resection for Stage I Esophageal Carcinoma: A Pilot Study
por: Yang, Xu, et al.
Publicado: (2021)

Postoperative radiotherapy improves survival of patients with ypN2 non‐small cell lung cancer after neoadjuvant chemotherapy followed by surgery – A propensity score matching study of the Surveillance, Epidemiology, and End Results database
por: Bao, Yongxing, et al.
Publicado: (2021)

The Optimal Treatment for Resectable Esophageal Cancer: A Network Meta-Analysis of 6168 Patients
por: Yuan, Meng, et al.
Publicado: (2021)

Comparison of different neoadjuvant treatments for resectable locoregional esophageal cancer: A systematic review and network meta‐analysis
por: Bao, Yongxing, et al.
Publicado: (2022)

Risk of cardiac‐related mortality in stage IIIA‐N2 non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database
por: Sun, Xin, et al.
Publicado: (2021)

Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer
por: Yuan, Meng, et al.
Publicado: (2022)

Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer
por: Yuan, Meng, et al.
Publicado: (2022)

The mapping of mRNA alterations elucidates the etiology of radiation-induced pulmonary fibrosis
por: Yuan, Meng, et al.
Publicado: (2022)

Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness
por: Zhao, Maoyuan, et al.
Publicado: (2020)

Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis
por: Liu, Yunsong, et al.
Publicado: (2023)

Higher Lung and Heart Doses Decrease Early and Long-Term Survival, Respectively, in Patients With Non-Small Cell Lung Cancer Undergoing Postoperative Radiation
por: Ma, Zeliang, et al.
Publicado: (2023)

Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomized controlled trial
por: Ma, Zeliang, et al.
Publicado: (2023)

Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma
por: Han, Weiming, et al.
Publicado: (2022)

Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer
por: Bao, Yongxing, et al.
Publicado: (2022)

High NANOG expression correlates with worse patients’ survival in esophageal adenocarcinoma
por: Knipper, Karl, et al.
Publicado: (2023)

Survival benefit of radiotherapy in metastatic esophageal cancer: a population-based study
por: Li, Xiangpan, et al.
Publicado: (2019)

Clinical Predictors of Locally Advanced Pathology in Esophageal Adenocarcinoma
por: Gomez Cifuentes, Juan David, et al.
Publicado: (2021)

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
por: Plum, Patrick Sven, et al.
Publicado: (2019)

CENPE expression is associated with its DNA methylation status in esophageal adenocarcinoma and independently predicts unfavorable overall survival
por: Zhu, Xueqiang, et al.
Publicado: (2019)

Development and validation of a survival model for esophageal adenocarcinoma based on autophagy-associated genes
por: Duan, Lili, et al.
Publicado: (2021)

An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma
por: Yang, Chuang, et al.
Publicado: (2023)

OSeac: An Online Survival Analysis Tool for Esophageal Adenocarcinoma
por: Wang, Qiang, et al.
Publicado: (2020)

Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma
por: Ten Kate, Fiebo J.C., et al.
Publicado: (2017)

Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study
por: McMenamin, Úna C., et al.
Publicado: (2018)

Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survival
por: Loeser, Heike, et al.
Publicado: (2020)

Incidence and Survival Changes in Patients with Esophageal Adenocarcinoma during 1984–2013
por: Haiyu, Zhang, et al.
Publicado: (2019)

CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma
por: Fehrenbach, Uli, et al.
Publicado: (2021)

Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis
por: Yuan, Meng, et al.
Publicado: (2021)

piRNAs may regulate expression of candidate genes of esophageal adenocarcinoma
por: Akimniyazova, A. N., et al.
Publicado: (2022)

Multivariable regulation of gene expression plasticity in metazoans
por: Xiao, Long, et al.
Publicado: (2019)

Predictive Model for Overall Survival and Cancer-Specific Survival in Patients with Esophageal Adenocarcinoma
por: Huang, He, et al.
Publicado: (2021)

Prognostic signature of esophageal adenocarcinoma based on pyroptosis-related genes
por: Li, Guo-Sheng, et al.
Publicado: (2022)

A comparative Analysis by SAGE of Gene Expression Profiles of Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma
por: van Baal, Jantine W. P. M., et al.
Publicado: (2008)

Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival
por: Faluyi, Olusola O., et al.
Publicado: (2017)

Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival
por: Karstens, Karl-Frederick, et al.
Publicado: (2020)

Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma
por: Xie, Shao‐Hua, et al.
Publicado: (2020)

MicroRNA-608 promotes apoptosis via BRD4 downregulation in pancreatic ductal adenocarcinoma
por: Li, Maoyuan, et al.
Publicado: (2020)

Postoperative radiotherapy for pathological stage IIIA‐N2 non‐small cell lung cancer with positive surgical margins
por: Yuan, Meng, et al.
Publicado: (2020)

Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy
por: Xu, Cai, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tj9p157k013eqlfd7d5r0kg43v